(Q35106856)

6 August 2017

1 reference

title

Comparison of efficacy criteria across onychomycosis trials: need for standardization (English)

1 reference

6 August 2017

Aditya K Gupta

1

0 references

author name string

Jennifer Ryder

series ordinal

2

1 reference

PubMed ID

12694503

6 August 2017

Richard C Summerbell

series ordinal

3

1 reference

6 August 2017

1 April 2003

1 reference

International Journal of Dermatology

6 August 2017

1 reference

6 August 2017

42

1 reference

6 August 2017

4

1 reference

6 August 2017

312-315

1 reference

Prevalence and epidemiology of unsuspected onychomycosis in patients visiting dermatologists' offices in Ontario, Canada--a multicenter survey of 2001 patients.

6 August 2017

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-4362.2003.01678.X

Itraconazole in the treatment of onychomycosis: a double-blind comparison with miconazole

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-4362.2003.01678.X

Antifungal pulse therapy for onychomycosis. A pharmacokinetic and pharmacodynamic investigation of monthly cycles of 1-week pulse therapy with itraconazole

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-4362.2003.01678.X

A double-blind, randomized study comparing itraconazole pulse therapy with continuous dosing for the treatment of toe-nail onychomycosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-4362.2003.01678.X

Therapeutic efficacy and safety of one-week intermittent therapy with itraconazole for onychomycosis in a Chinese patient population.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-4362.2003.01678.X

Randomised double blind comparison of terbinafine and itraconazole for treatment of toenail tinea infection. Seventh Lamisil German Onychomycosis Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-4362.2003.01678.X

Evaluation of 6 weeks treatment of terbinafine in tinea unguium in a double-blind trial comparing 6 and 12 weeks therapy. The Lagos V Study Group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-4362.2003.01678.X

Double blind, randomised study of continuous terbinafine compared with intermittent itraconazole in treatment of toenail onychomycosis. The LION Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-4362.2003.01678.X

Single-blind, randomized, prospective study of sequential itraconazole and terbinafine pulse compared with terbinafine pulse for the treatment of toenail onychomycosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-4362.2003.01678.X

Randomized double-blind comparison of short-term itraconazole and terbinafine therapy for toenail onychomycosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-4362.2003.01678.X

Efficacy of terbinafine for toenail onychomycosis. A multicenter trial of various treatment durations

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-4362.2003.01678.X

Treatment of tinea unguium with medium and high doses of ultramicrosize griseofulvin compared with that with itraconazole

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-4362.2003.01678.X

Ciclopirox nail lacquer topical solution 8% in the treatment of toenail onychomycosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-4362.2003.01678.X

The new oral antifungal agents for onychomycosis of the toenails

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-4362.2003.01678.X

10.1046/J.1365-4362.2003.01678.X

21 January 2018

Identifiers

DOI

1 reference

6 August 2017

1 reference

PubMed ID

12694503